News Focus
News Focus
icon url

EndoTarget

04/28/21 9:18 AM

#338239 RE: Bluerinse #338238

RS 3:1
icon url

ibelurkin

04/28/21 10:33 AM

#338242 RE: Bluerinse #338238

You're misstating what was posted.

50 to 60 in 12 to 18 months.

If you want growth like this you have to pay up.
icon url

ibelurkin

04/28/21 6:41 PM

#338263 RE: Bluerinse #338238

Bluerinse

I completely understand the mild sarcasm bestowed upon me for even suggesting a 3 billion market cap when sales are a poultry 100m.

I'm not opposed to having an open discussion here about how I arrived at my valuation, I'm always eager to learn. ( real sarcasm as opposed to mild sarcasm)

Let's start off with you throwing out price target with the current share structure in 18 months.



I know I'm close to being on target or you wouldn't have all these institutions buying stock right now with hundreds of millions of dollars. It's a confirmation of my valuation. I don't see how you missed it.

Fund managers are not putting all that money to work to make a couple bucks a share oh hell, to lose money since the price target is below the current price.

And valuation on this company is not as simple as using common metrics.

There is a bevy of considerations that goes into valuing a cdmo.